Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Milestone Scientific stock price, quote, forecast and news

MLSS
US59935P2092
A0BMS5

Price

1.00
Today +/-
-0.03
Today %
-3.13 %
P

Milestone Scientific stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Milestone Scientific stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Milestone Scientific stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Milestone Scientific stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Milestone Scientific's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Milestone Scientific Stock Price History

DateMilestone Scientific Price
9/9/20241.00 undefined
9/6/20241.03 undefined
9/5/20241.02 undefined
9/4/20240.98 undefined
9/3/20241.01 undefined
8/30/20241.10 undefined
8/29/20240.97 undefined
8/28/20240.96 undefined
8/27/20241.00 undefined
8/26/20241.00 undefined
8/23/20241.04 undefined
8/22/20241.02 undefined
8/21/20241.00 undefined
8/20/20240.93 undefined
8/19/20240.95 undefined
8/16/20240.97 undefined
8/15/20240.98 undefined
8/14/20241.01 undefined
8/13/20241.02 undefined
8/12/20241.01 undefined

Milestone Scientific Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Milestone Scientific, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Milestone Scientific from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Milestone Scientific’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Milestone Scientific. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Milestone Scientific’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Milestone Scientific’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Milestone Scientific’s growth potential.

Milestone Scientific Revenue, EBIT and net profit per share

DateMilestone Scientific RevenueMilestone Scientific EBITMilestone Scientific Net Income
2026e16.39 M undefined-8.23 M undefined-9.04 M undefined
2025e12.08 M undefined-3.98 M undefined-2.37 M undefined
2024e9.62 M undefined-4.65 M undefined-3.15 M undefined
20239.83 M undefined-7.11 M undefined-6.93 M undefined
20228.81 M undefined-8.83 M undefined-8.71 M undefined
202110.3 M undefined-7.38 M undefined-6.82 M undefined
20205.44 M undefined-7.45 M undefined-7.34 M undefined
20198.37 M undefined-4 M undefined-7.52 M undefined
20189.62 M undefined-6.46 M undefined-7.43 M undefined
201711.28 M undefined-5.23 M undefined-5.19 M undefined
201610.48 M undefined-6.51 M undefined-5.95 M undefined
20159.49 M undefined-3.06 M undefined-5.47 M undefined
201410.33 M undefined-790,000 undefined-1.7 M undefined
201310.01 M undefined1.09 M undefined1.46 M undefined
20128.65 M undefined-520,000 undefined-870,000 undefined
20118.38 M undefined-1.22 M undefined-1.48 M undefined
20109.75 M undefined-700,000 undefined-610,000 undefined
20098.55 M undefined-2.1 M undefined-1.53 M undefined
20086.62 M undefined-1.73 M undefined-1.19 M undefined
20076.39 M undefined-3.48 M undefined-2.94 M undefined
20065.84 M undefined-3.52 M undefined-3.15 M undefined
20056.43 M undefined-3.25 M undefined-2.76 M undefined
20044.75 M undefined-3.01 M undefined-3 M undefined

Milestone Scientific Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (k)EBIT MARGIN (%)NET INCOME (k)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e
002825443465668988101091011985108991216
---300.00-75.00150.00-20.00--25.0033.3350.00-16.6720.00-33.3312.50-11.11-25.00--10.0011.1110.00-18.18-11.11-37.50100.00-20.0012.50-33.3333.33
--50.00-12.5050.0040.0050.0050.0033.3350.0050.0040.0050.0050.0062.5066.6762.5062.5060.0060.0066.6760.0054.5544.4462.5060.0060.0050.0066.67---
001-11222123233565566666453646000
0-2,000-7,000-11,000-6,000-5,000-3,000-1,000-1,000-3,000-3,000-3,000-3,000-1,000-2,0000-1,00001,0000-3,000-6,000-5,000-6,000-4,000-7,000-7,000-8,000-7,000-4,000-3,000-8,000
---350.00-137.50-300.00-100.00-75.00-25.00-33.33-75.00-50.00-60.00-50.00-16.67-25.00--12.50-10.00--33.33-60.00-45.45-66.67-50.00-140.00-70.00-100.00-77.78-44.44-25.00-50.00
0-1,000-7,000-10,000-6,000-7,000-3,000-2,000-2,000-3,000-2,000-3,000-2,000-1,000-1,0000-1,00001,000-1,000-5,000-5,000-5,000-7,000-7,000-7,000-6,000-8,000-6,000-3,000-2,000-9,000
--600.0042.86-40.0016.67-57.14-33.33-50.00-33.3350.00-33.33-50.00------200.00400.00--40.00---14.2933.33-25.00-50.00-33.33350.00
1.051.522.042.912.913.53.714.164.679.1511.0111.7912.1412.6713.3914.8215.1716.0817.4820.0621.4326.9732.735.345.7463.0668.8370.6172.78000
--------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Milestone Scientific Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Milestone Scientific is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (k)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (k)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (k)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (k)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
1996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                       
0.7815.553.590.240.170.020.0103.042.891.160.750.741.030.630.10.171.1510.374.193.62.640.741.5214.2214.768.725.95
0.320.320.430.30.530.360.240.390.420.350.350.350.931.060.81.150.981.531.541.793.523.262.081.711.080.940.690.31
00000000000000000006010500000000
0.511.251.260.711.040.480.420.6612.392.42.290.970.961.721.741.122.053.225.475.34.082.572.332.832.853.124.01
0.020.10.130.190.220.030.230.150.110.30.160.190.220.250.250.30.240.150.450.30.911.550.460.520.420.380.440.52
1.6317.225.411.441.960.890.91.24.575.934.073.582.863.33.43.292.514.8815.5811.8113.3412.035.856.0818.5518.9312.9710.79
0.280.762.031.670.270.210.230.240.610.540.460.220.150.080.070.050.040.020.090.240.160.140.080.060.660.570.480.37
0000000000000000.1200.971.260.0200000000
0001.010.310.380.0900000.540.420.312.072.722.471.580000.65000000
2.041.981.741.4900000.10.490.530.560.90.950.940.70.650.590.530.720.662.790.440.380.330.280.230.18
0000000000000000000000000000
700303010105030280901009010080210130100101010202030304020202024.15
3.022.773.84.180.590.640.350.520.81.131.081.421.551.553.213.693.173.171.8910.843.610.550.481.010.870.730.58
4.6519.999.215.622.551.531.251.725.377.065.1554.414.856.616.985.688.0517.4712.8114.1815.646.46.5619.5619.813.711.37
                                                       
10101010101010101010101010202020202020203030405060707075.88
6.8228.6930.1130.8834.5836.0936.642.6652.6257.1757.7258.4859.5362.362.6163.6964.5666.6877.578.6382.7686.6988.4196.08117.93124.92127.48132.19
-2.74-10.17-20.87-27.85-35.36-39.35-41.79-44.2-47.2-49.96-53.11-56.05-57.23-58.76-59.38-60.86-61.73-60.27-61.97-67.43-73.38-78.57-86-93.52-100.89-107.7-116.41-123.34
-0.13000-0.03-0.3-0.02000000000000000000000
0000000000000000000000000000
3.9618.539.253.04-0.8-3.55-5.2-1.535.437.224.622.442.313.563.252.852.856.4315.5511.229.418.152.452.6117.117.2911.148.92
0.481.050.5511.151.061.271.690.470.511.21.860.831.152.883.932.342.021.452.092.581.962.872.740.871.181.911.1
0.10.250.170.250.360.110.260.290.230.220.230.20.50.520.510.680.940.520.981.561.442.291.481.851.481.911.381.97
0.040000.14000.640000.02000000001.632.480.520.340.24000
80180150000000000000000000000280000
00000.204.581.500000000000000000.010.010.010.01
0.71.480.871.251.851.176.114.120.70.731.432.081.331.673.394.613.282.542.433.655.656.734.874.932.883.13.33.08
0002.252.43.750.780.040000.941.690.440.880.450.4500000000.030.020.010
0000000000000000000000000000
000001.050.4600.15000.4400.0900000001.4000.560.480.390.28
0002.252.44.81.240.040.15001.381.690.530.880.450.4500001.4000.590.50.40.28
0.71.480.873.54.255.977.354.160.850.731.433.463.022.24.275.063.732.542.433.655.658.134.874.933.473.63.73.36
4.6620.0110.126.543.452.422.152.636.287.956.055.95.335.767.527.916.588.9717.9814.8715.0616.287.327.5420.5720.8914.8412.28
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Milestone Scientific provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Milestone Scientific's financial health and stability.

Assets

Milestone Scientific's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Milestone Scientific must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Milestone Scientific after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Milestone Scientific's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (k)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (k)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
19951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
0-1,000-7,000-10,000-6,000-7,000-3,000-2,000-2,000-3,000-2,000-3,000-2,000-1,000-1,0000-1,00001,000-1,000-5,000-7,000-5,000-7,000-7,000-7,000-6,000-8,000-6,000
00000000000000000000000000000
00000000000000000000000000000
000-100000-1-1000000000-10211-100-1
00230311100010100001300332132
00000000000000000000000000000
00000000000000000000000000000
0-1,000-4,000-8,000-5,000-2,000-1,00000-4,000-3,000-1,000-1,000000001,0000-2,000-5,000-1,000-1,000-1,000-6,000-4,000-6,000-5,000
000-30000000000000000000000000
-20-6-1300000000000000-1-30000000-2
-20-52300000000000000-1-30000000-2
00000000000000000000000000000
00002200000010000000000000000
4019000000000000000090400219402
40190221007301000000100400219402
00000000073000000000000000000
00000000000000000000000000000
2-19-90000030-100000009-600-10120-6-5
-0.06-1.55-5.16-12.24-5.44-2.89-1.39-0.75-0.86-4.72-3.6-1.73-1.49-0.760.23-0.4-0.61-0.081.230.28-3.03-5.43-1.43-1.64-1.79-7-4.05-6.04-5.33
00000000000000000000000000000

Milestone Scientific stock margins

The Milestone Scientific margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Milestone Scientific. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Milestone Scientific.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Milestone Scientific's sales revenue. A higher gross margin percentage indicates that the Milestone Scientific retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Milestone Scientific's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Milestone Scientific's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Milestone Scientific's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Milestone Scientific. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Milestone Scientific's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Milestone Scientific Margin History

Milestone Scientific Gross marginMilestone Scientific Profit marginMilestone Scientific EBIT marginMilestone Scientific Profit margin
2026e69.12 %-50.23 %-55.17 %
2025e69.12 %-32.91 %-19.57 %
2024e69.12 %-48.29 %-32.77 %
202369.12 %-72.31 %-70.51 %
202255.62 %-100.23 %-98.86 %
202161.26 %-71.65 %-66.21 %
202066.54 %-136.95 %-134.93 %
201968.34 %-47.79 %-89.84 %
201846.05 %-67.15 %-77.23 %
201761.79 %-46.37 %-46.01 %
201660.21 %-62.12 %-56.77 %
201567.86 %-32.24 %-57.64 %
201464.86 %-7.65 %-16.46 %
201368.03 %10.89 %14.59 %
201264.62 %-6.01 %-10.06 %
201163.96 %-14.56 %-17.66 %
201063.79 %-7.18 %-6.26 %
200959.53 %-24.56 %-17.89 %
200859.52 %-26.13 %-17.98 %
200754.62 %-54.46 %-46.01 %
200647.95 %-60.27 %-53.94 %
200559.56 %-50.54 %-42.92 %
200449.26 %-63.37 %-63.16 %

Milestone Scientific Stock Sales Revenue, EBIT, Earnings per Share

The Milestone Scientific earnings per share therefore indicates how much revenue Milestone Scientific has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Milestone Scientific earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Milestone Scientific's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Milestone Scientific’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Milestone Scientific's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Milestone Scientific Revenue, EBIT and net profit per share

DateMilestone Scientific Sales per ShareMilestone Scientific EBIT per shareMilestone Scientific Earnings per Share
2026e0.21 undefined0 undefined-0.12 undefined
2025e0.16 undefined0 undefined-0.03 undefined
2024e0.12 undefined0 undefined-0.04 undefined
20230.14 undefined-0.1 undefined-0.1 undefined
20220.12 undefined-0.13 undefined-0.12 undefined
20210.15 undefined-0.11 undefined-0.1 undefined
20200.09 undefined-0.12 undefined-0.12 undefined
20190.18 undefined-0.09 undefined-0.16 undefined
20180.27 undefined-0.18 undefined-0.21 undefined
20170.34 undefined-0.16 undefined-0.16 undefined
20160.39 undefined-0.24 undefined-0.22 undefined
20150.44 undefined-0.14 undefined-0.26 undefined
20140.51 undefined-0.04 undefined-0.08 undefined
20130.57 undefined0.06 undefined0.08 undefined
20120.54 undefined-0.03 undefined-0.05 undefined
20110.55 undefined-0.08 undefined-0.1 undefined
20100.66 undefined-0.05 undefined-0.04 undefined
20090.64 undefined-0.16 undefined-0.11 undefined
20080.52 undefined-0.14 undefined-0.09 undefined
20070.53 undefined-0.29 undefined-0.24 undefined
20060.5 undefined-0.3 undefined-0.27 undefined
20050.58 undefined-0.3 undefined-0.25 undefined
20040.52 undefined-0.33 undefined-0.33 undefined

Milestone Scientific business model

Milestone Scientific Inc. is a US-based company specializing in the development and distribution of medical instruments. It was founded in 1989 as a subsidiary of a Swiss-based company and has since expanded its business to various markets. Milestone Scientific's business model focuses on developing and selling innovative medical devices that enhance capabilities and outcomes in dentistry, medicine, and veterinary medicine. The company aims to produce high-quality products that meet the highest industry standards while benefiting both patients and healthcare professionals. The company offers a wide range of products and services, including handpieces, high-speed drill units, injection systems, anesthesia devices, and other medical instruments. Some of Milestone Scientific's most well-known products are their dental drill units, which allow for the delivery of anesthetics and other fluids with minimal pain. These units are leading in the industry and highly valued by dentists worldwide. Milestone Scientific has also specialized in the development of injection systems, which are particularly sought after by dentists and veterinarians. These injection systems minimize the use of needles, resulting in reduced pain, lower infection risks, and faster patient recovery. The company is divided into different divisions, allowing Milestone Scientific to tailor its products and services to different specialties and markets. The dental division focuses on products and services specifically designed for use in dentistry, including high-speed drill units, injection systems, and other instruments used in dental treatments. The medical technology division focuses on developing and manufacturing instruments and services used in general medicine and anesthesia. Products in this division include anesthesia devices, injection systems, and other medical instruments that help minimize the use of needles and related risks. The veterinary division offers products and services tailored to the needs of veterinarians. These include injection systems, handpieces, and other instruments that improve the effectiveness of veterinarians in animal treatment. Overall, since its founding, Milestone Scientific has had an impressive success story in the medical industry. The company has earned a good reputation among healthcare professionals and patients, and its products and services are used in many countries worldwide. With its innovative approach and high-quality products, Milestone Scientific is likely to continue playing a crucial role in the medical industry in the future. Milestone Scientific is one of the most popular companies on Eulerpool.com.

Milestone Scientific SWOT Analysis

Strengths

Milestone Scientific Inc has several strengths that contribute to its success. One of its main strengths is its innovative and patented medical instruments, such as the CompuFlo® and The Wand®, which have gained recognition for their precision and effectiveness in painless injections.

Additionally, the company has a strong research and development team, allowing them to constantly improve their existing products and develop new ones. This enables them to stay ahead of the competition and meet the evolving needs of healthcare providers and patients.

Weaknesses

Despite its strengths, Milestone Scientific Inc also faces some weaknesses. One significant weakness is its limited market penetration. While the company has seen success in certain markets, it still has room to expand and reach a wider customer base.

Another weakness is their reliance on a few key customers for a significant portion of their revenue. This increases their vulnerability to any changes in the purchasing decisions of these customers or disruptions in their business operations.

Opportunities

Milestone Scientific Inc has various opportunities that can fuel its future growth. The increasing demand for painless injections and the growing emphasis on patient comfort and safety provide a favorable market environment for the company to thrive. By capitalizing on these trends, they can further expand their customer base and increase sales.

Additionally, the company can explore potential collaborations and partnerships with healthcare providers or pharmaceutical companies to enhance their product offerings and enter new markets. Acquisitions or mergers may also provide opportunities for diversification and economies of scale.

Threats

Milestone Scientific Inc faces certain threats that could impact its business. The competitive landscape in the medical instruments industry is intense, with several established players and new entrants. This heightens the need for continuous innovation, effective marketing strategies, and strong customer relationships to maintain market share.

Another threat is the regulatory environment. Changes in regulations and compliance requirements can pose challenges for the company and its products. Adapting to evolving regulations and ensuring product compliance are essential to avoid any legal or reputational risks.

Milestone Scientific Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Milestone Scientific historical P/E ratio, EBIT, and P/S ratio.

Milestone Scientific shares outstanding

The number of shares was Milestone Scientific in 2023 — This indicates how many shares 72.776 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Milestone Scientific earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Milestone Scientific's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Milestone Scientific’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Milestone Scientific's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for Milestone Scientific.

Milestone Scientific latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/2024-0.01 -0.02  (-96.08 %)2024 Q2
3/31/2024-0.02 -0.02  (1.96 %)2024 Q1
6/30/2023-0.02 -0.03  (-47.06 %)2023 Q2
3/31/2023-0.03 -0.02  (34.64 %)2023 Q1
12/31/2022-0.03 -0.02  (34.64 %)2022 Q4
9/30/2022-0.03 -0.03  (1.96 %)2022 Q3
6/30/2022-0.03 -0.04  (-30.72 %)2022 Q2
3/31/2022-0.03 -0.03  (1.96 %)2022 Q1
12/31/2021-0.03 -0.02  (34.64 %)2021 Q4
9/30/2021-0.03 -0.03  (-17.65 %)2021 Q3
1
2
3
4

Eulerpool ESG Scorecard© for the Milestone Scientific stock

Eulerpool World ESG Rating (EESG©)

28/ 100

🌱 Environment

31

👫 Social

20

🏛️ Governance

32

Environment

Scope 1 - Direct Emissions
—
Scope 2 - Indirect emissions from purchased energy
—
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
—
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
✅
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
❌
Hazardous substances
❌
Fuel consumption and efficiency
❌
Water consumption and efficiency
❌

Social

Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept❌
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting❌
Stakeholder Engagement❌
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Milestone Scientific list of shareholders

%
Name
Stocks
Change
Date
5.03669 % BP4 S.r.l.3,892,85703/15/2024
5.02840 % Osser (Leonard A)3,886,453326,2633/15/2024
2.77495 % The Vanguard Group, Inc.2,144,75538012/31/2023
2.73364 % Goldman (Neal I)2,112,83403/15/2024
0.64911 % Bridgeway Capital Management, LLC501,700012/31/2023
0.62642 % McGeehan (Michael)484,157134,8313/15/2024
0.55669 % Trombetta (Gian Domenico)430,263-13/15/2024
0.53615 % Geode Capital Management, L.L.C.414,389012/31/2023
0.34889 % Casamento Benedetta I269,65903/15/2024
0.32583 % swisspartners Ltd.251,833012/31/2022
1
2
3
4
5
...
7

Milestone Scientific Executives and Management Board

Mr. Jan Haverhals60
Milestone Scientific President, Chief Executive Officer, Director, Chief Executive Office of Milestone Dental Division (since 2020)
Compensation 841,141
Ms. Benedetta Casamento53
Milestone Scientific Independent Director
Compensation 112,877
Mr. Michael McGeehan57
Milestone Scientific Independent Director
Compensation 102,500
Mr. Neal Goldman79
Milestone Scientific Independent Chairman of the Board
Compensation 100,000
Mr. Leonard Osser75
Milestone Scientific Vice Chairman of the Board (since 1991)
Compensation 100,000
1
2

Most common questions regarding Milestone Scientific

What values and corporate philosophy does Milestone Scientific represent?

Milestone Scientific Inc represents values of innovation, excellence, and patient-centricity. With a strong corporate philosophy focused on improving patient outcomes, Milestone Scientific Inc is committed to developing cutting-edge medical solutions. Through their revolutionary technologies and advancements, such as the CompuFlo® and the Wand® system, the company strives to enhance precision and efficiency in drug delivery and anesthesia procedures. Milestone Scientific Inc aims to provide healthcare professionals with state-of-the-art tools that improve patient safety, reduce discomfort, enhance accuracy, and optimize drug delivery processes. Their commitment to advancing medical technology aligns with their dedication to revolutionizing the field and improving patient experience.

In which countries and regions is Milestone Scientific primarily present?

Milestone Scientific Inc is primarily present in the United States and select countries and regions around the world.

What significant milestones has the company Milestone Scientific achieved?

Milestone Scientific Inc has achieved several significant milestones in its history. The company introduced the revolutionary CompuFlo® technology, which revolutionized the field of computer-controlled drug delivery. Milestone Scientific Inc also developed the award-winning STA Single Tooth Anesthesia System®, a patented device that provides precise and virtually painless anesthesia for dental procedures. Furthermore, the company successfully expanded its product portfolio by acquiring Wand Dental Inc., a leading manufacturer of high-quality dental products. These achievements have solidified Milestone Scientific Inc's reputation as an innovative and industry-leading company in the medical and dental sectors.

What is the history and background of the company Milestone Scientific?

Milestone Scientific Inc. is a medical device company founded in 1989. The company specializes in developing and commercializing innovative injection technologies for the medical and dental fields. With its patented computer-controlled injection systems, Milestone Scientific aims to provide precise and painless drug delivery to enhance patient comfort and safety. The company's products have gained recognition globally, addressing various applications such as dentistry, cosmetic surgery, and healthcare research. Milestone Scientific Inc. continues to focus on research and development, aiming to expand its product portfolio and improve medical practices worldwide.

Who are the main competitors of Milestone Scientific in the market?

The main competitors of Milestone Scientific Inc in the market include companies such as Dentsply Sirona, Henry Schein, Inc., and Patterson Companies, Inc.

In which industries is Milestone Scientific primarily active?

Milestone Scientific Inc is primarily active in the medical and dental industries.

What is the business model of Milestone Scientific?

Milestone Scientific Inc.'s business model focuses on designing, developing, manufacturing, and marketing innovative medical devices and instruments. Their core technologies include CompuFlo® for precise and controlled drug delivery, and the STA Single Tooth Anesthesia System® for painless and efficient dental injections. Milestone Scientific Inc. aims to provide medical professionals with advanced solutions that improve patient outcomes, increase efficiency, and reduce costs. With a strong commitment to cutting-edge research and development, they continually strive to enhance their product portfolio and meet the evolving needs of the healthcare industry.

What is the P/E ratio of Milestone Scientific 2024?

The Milestone Scientific P/E ratio is -23.04.

What is the P/S ratio of Milestone Scientific 2024?

The Milestone Scientific P/S ratio is 7.55.

What is the AlleAktien quality score of Milestone Scientific?

The AlleAktien quality score for Milestone Scientific is 2/10.

What is the revenue of Milestone Scientific 2024?

The expected Milestone Scientific revenue is 9.62 M USD.

How high is the profit of Milestone Scientific 2024?

The expected Milestone Scientific profit is -3.15 M USD.

What is the business model of Milestone Scientific

Milestone Scientific Inc is an innovative company that develops and manufactures medical devices and instruments. The company's business model focuses on providing high-tech solutions for the medical industry and is based on three key pillars: medical devices, dental applications, and product marketing.

What is the Milestone Scientific dividend?

Milestone Scientific pays a dividend of 0 USD distributed over payouts per year.

How often does Milestone Scientific pay dividends?

The dividend cannot currently be calculated for Milestone Scientific or the company does not pay out a dividend.

What is the Milestone Scientific ISIN?

The ISIN of Milestone Scientific is US59935P2092.

What is the Milestone Scientific WKN?

The WKN of Milestone Scientific is A0BMS5.

What is the Milestone Scientific ticker?

The ticker of Milestone Scientific is MLSS.

How much dividend does Milestone Scientific pay?

Over the past 12 months, Milestone Scientific paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Milestone Scientific is expected to pay a dividend of 0 USD.

What is the dividend yield of Milestone Scientific?

The current dividend yield of Milestone Scientific is .

When does Milestone Scientific pay dividends?

Milestone Scientific pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Milestone Scientific?

Milestone Scientific paid dividends every year for the past 0 years.

What is the dividend of Milestone Scientific?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Milestone Scientific located?

Milestone Scientific is assigned to the 'Health' sector.

Wann musste ich die Aktien von Milestone Scientific kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Milestone Scientific from 9/10/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/10/2024.

When did Milestone Scientific pay the last dividend?

The last dividend was paid out on 9/10/2024.

What was the dividend of Milestone Scientific in the year 2023?

In the year 2023, Milestone Scientific distributed 0 USD as dividends.

In which currency does Milestone Scientific pay out the dividend?

The dividends of Milestone Scientific are distributed in USD.

All fundamentals about Milestone Scientific

Our stock analysis for Milestone Scientific Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Milestone Scientific Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.